Assets

Applications

Medicine

Identify novel Biosynthetic Gene Clusters and enzyme for therapeutic compound production.

Agriculture

Identify microbes that have the appropriate profile for biopesticides and fertilizer additives, providing environment and human friendly alternatives to conventional agricultural chemicals.

More...

Replace industrial methods of chemical production by using microbes to achieve sustainability goals.

Our Asset Pipeline

We have multiple assets in development, the most mature being our biopesticide candidates.

Commerical Assets

Asset

Initial POC

Feasibility Study

Licensing

Seed-Treatment Biopesticide

Two candidates passed initial Feasibility Study test with partner company.

Bio-Insecticide

Multiple candidates available for co-development/out licensing partnership.

High-Quality BGCs

Multiple Actinomyces collected. Analysis in progress.

Clinical Assets

Asset

Preclinical

Clinical 1

Clinical 2

Clinical 3

MRSA Antibiotic

Novel active compounds found from wet-lab screen.

On-Target

clinical product / genetic engineering asset

Our fusion protein shows efficacy for targeted DNA insertion in e-coli. Patent filed (Jan, 2022)